Lucy Day
Direttore Finanziario/CFO presso AN2 THERAPEUTICS, INC.
Patrimonio netto: 60 948 $ in data 31/05/2024
Posizioni attive di Lucy Day
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| AN2 THERAPEUTICS, INC. | Direttore Finanziario/CFO | 01/11/2019 | - |
Storia della carriera di Lucy Day
Precedenti posizioni note di Lucy Day
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ANACOR PHARMACEUTICALS INC | Direttore Finanziario/CFO | 01/03/2002 | 01/08/2016 |
| Ufficiale delle Risorse Umane | 01/03/2002 | 01/08/2016 | |
| Centaur Pharmaceuticals, Inc. | Direttore Finanziario/CFO | 01/02/1994 | 01/01/2002 |
| MERRILL LYNCH PREFERRED CAPITAL TRUST I | Corporate Officer/Principal | 01/01/1990 | 01/01/1994 |
Formazione di Lucy Day
| University of California, Berkeley | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
Posizioni
| Director of Finance/CFO | 3 |
| Human Resources Officer | 1 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 2 |
| Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| AN2 THERAPEUTICS, INC. | Health Technology |
| MERRILL LYNCH PREFERRED CAPITAL TRUST I | Finance |
| Aziende private | 2 |
|---|---|
Anacor Pharmaceuticals LLC
 Anacor Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Anacor Pharmaceuticals, Inc. develops medical solutions. The firm operates as a biopharmaceutical company, which focuses on discovering, developing, and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. The company was founded by Lucy Shapiro, Stephen J. Benkovic, and David P. Perry in 2000 and is headquartered in Palo Alto, CA. | Health Technology |
| Centaur Pharmaceuticals, Inc. | Health Technology |
- Borsa valori
- Insiders
- Lucy Day
- Esperienza
